U.S. Food and Drug Administration

Get your COVID-19 vaccine or booster today!

Find out where to get a COVID-19 vaccine, test, or treatment in your community. Call 1-800-232-0233 with questions.

COVID.gov

Featured

FDA COVID-19 Response

FDA is working with U.S. government partners, including CDC, and international partners to address the pandemic.

Food

Drugs

Medical Devices

Radiation-Emitting Products

Vaccines, Blood, and Biologics

Animal and Veterinary

Cosmetics

Tobacco Products

New Era of Smarter Food Safety

A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.

Science-related icons juxtoposed on a background of prescription paperwork

Fostering Drug Competition

Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.

Closeup shot of a nurse holding a patient's hand in comfort in a hospital

Combating the Opioid Crisis

FDA takes actions to combat prescription opioid abuse.

May 24

FDA Roundup: May 24, 2022

May 20

FDA Approves First Treatment for Eosinophilic Esophagitis, a Chronic Immune Disorder

More Press Announcements

Newsroom Meetings Testimony Speeches

May 24

Coblentz Chocolate Company Recalls Select Peanut Butter Products Because of Possible Health Risk

Food & Beverages

May 24

Mary’s Harvest Fresh Foods, Inc. Issues Voluntary Recall of Celery Peanut Butter Cup G&G and Apple Peanut Butter Cup G&G Because of Possible Health Risk

Food & Beverages

May 24

Garden Cut, LLC Recalls Snack Cups Containing Jif® Peanut Butter Due to the Potential for Salmonella Contamination

Food & Beverages

More Recalls Market Withdrawals & Safety Alerts Subscribe to the Enforcement Report Mailing List

Paragraph Header

Illustration graphic of woman holding pendulum with internet cloud icon, about to let go into other pendulum balls with apple, pills, syringe, and microscope icons. Right side of illustration is the report cover of the Enterprise Modernization Action Plan (EMAP).

FDA's “All-in” Approach to Enterprise Transformation

The Enterprise Modernization Action Plan is the next phase of FDA’s data and technology transformation and describes our plans to shape the agency’s future.

Three image collage depicting a group of lab workers in white coats. Yellow pills being sorted by machinery, and a pharmacist holding a bottle of pills, conversing with a patient.

FDA Seeks to Engage Stakeholders on Key Considerations for a Drug Quality Management Maturity Program

Program Aims to Improve Drug Supply Chain, Mitigate Shortages

Give Your Community a Boost: Combatting Misinformation Through Communication and Research

During National Minority Health Month, we highlight the ways in which we are working to improve minority health and health equity.

May 24

Antibacterial Therapies for Patients With an Unmet Medical Need for the Treatment of Serious Bacterial Diseases – Questions and Answers (Revision 1)

Drugs

May 23

Compliance Policy Regarding Blood and Blood Component Donation Suitability, Donor Eligibility and Source Plasma Quarantine Hold Requirements

Biologics

May 23